UNSPSC 51151534: Aceclidine salicylate

This classification denotes the salicylate form of a cholinergic agonist with the molecular formula C9H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0578K3ELIO, chemically known as 3-quinuclidinol, acetate (ester) but more generally known as aceclidine, which bears US NIH Compound Identifier 1979. Aceclidine most often comes in forms base, hydrochloride, and salicylate. European Medicines Agency schedules Aceclidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05199MIG.

UNSPSC 51151534 Aceclidine salicylate is a Commodity code that does not align with the state and local procurement activity tagged under it. The two recent opportunities attributed to this code concern naloxone procurement and pharmaceutical benefit management program design—neither involves aceclidine salicylate or products of similar pharmacological scope. Seminole County, Florida's IFB 60459723LAS solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health support, while the Texas Health and Human Services Commission's RFI HHS0017013 explores direct-to-manufacturer prescription contracting models for a state pharmacy benefit program. These procurements fall into broader pharmaceutical procurement categories rather than the specific active pharmaceutical ingredient (API) or chemical compound this code nominally describes.

The geographic spread of recent activity under this code is limited to Florida and Texas, with no apparent pattern of repeat issuing bodies or sustained procurement demand for aceclidine salicylate specifically. The code shows little relevant recent activity, and the opportunities present in the source appear to be misclassified tagging errors rather than genuine demand signals for this particular commodity. Business development professionals evaluating this code should verify whether state and local procurement offices are actually sourcing aceclidine salicylate products or whether the code requires manual review and potential reclassification in the underlying opportunity database.